RT Journal Article
SR Electronic
T1 Computational methods for continuous eye-tracking perimetry based on spatio-temporal integration and a deep recurrent neural network
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.22.20106401
DO 10.1101/2020.05.22.20106401
A1 Alessandro Grillini
A1 Alex Hernández-García
A1 Remco J. Renken
A1 Giorgia Demaria
A1 Frans W. Cornelissen
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.22.20106401.abstract
AB Perimetry, the mapping of the sensitivity of different visual field locations, is an essential procedure in ophthalmology. Unfortunately, standard automated perimetry (SAP), suffers from some practical issues: it can be tedious, requires manual feedback and a high level of patient compliance. These factors limit the effectiveness of perimetry in some clinical populations. In an attempt to remove some of these limitations, alternatives to SAP have been tried based on tracking eye movements. These new approaches have attempted to mimic SAP, thus presenting stimuli on a fixed grid, and replacing manual by ocular responses. While this solves some issues of SAP, these approaches hardly exploit the high spatial and temporal resolution facilitated by eye-tracking. In this study, we present two novel computational methods that do tap into this potential: (1) an analytic method based on the spatio-temporal integration of positional deviations by means of Threshold Free Cluster Enhancement (TFCE) and (2) a method based on training a recursive deep artificial neural network (RNN). We demonstrate that it is possible to reconstruct visual field maps based on continuous gaze-tracking data acquired in a relatively short amount of time.Competing Interest StatementAG, AHG, and RJR: listed as inventors on the European patent application Grillini, A., Hernández-García, A., Renken, J. R. (2019). Method, system and computer program product for mapping a visual field. EP19209204.7 which is partially based on the content of this manuscript. AG: majority shareholder of REPERIO B.V., a private company that develops ophthalmic and neurological tests based on eye-movements. GD: none; FWC: none.Funding StatementThis project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreements No 641805 (NextGenVis) and No 675033 (EGRET+).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Medical Ethical Committee of the University Medical Center Groningen and the Ethics Committee of Psychology of the University of Groningen. The study followed the tenets of the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request to the corresponding author.